FDC Limited October 13, 2025, 12:57 am IST

NSE: 456.05 (6.65 | 1.48%)

BSE: 456.10 (6.65 | 1.48%)

INVESTORS > Corporate Governance

Corporate Governance

Board of Directors Policies Familiarisation Programme Committees Amalgamation Others

Board of Directors

CA. Uday Kumar Gurkar

Chairman & Non-Executive Independent Director

Mr. Mohan A. Chandavarkar

Managing Director

Mr. Nandan M. Chandavarkar

Joint Managing Director

Mr. Ashok A. Chandavarkar

Executive Director

Mr. Ameya A. Chandavarkar

CEO-International Business & Executive Director

Ms. Nomita R. Chandavarkar

Non-Executive Non-Independent Director

Dr. Charuta Nityanath Mandke

Non-Executive Independent Director

Dr. Mahesh Bijlani

Non-Executive and Independent Director

Mr. Vijay Suresh Maniar

Non-Executive and Independent Director

Mr. Vijay Nautamlal Bhatt

Non-Executive and Independent Director

Policies

Corporate Social Responsibility Policy

View

POLICY FOR PREVENTION, PROHIBITION AND REDRESSAL OF SEXUAL HARASSMENT AT WORKPLACE

View

Code of Practices & Procedures for Fair Disclosure of Unpublished Price Sensitive Information

View

Code Of Conduct For Prevention Of Insider Trading

View

Policy on Material Subsidiaries

View

Policy on Criteria for Determining Materiality of Events

View

Policy on Preservation of Documents

View

Policy on Dividend Distribution

View

Articles of Association of the Company

View

Whistle Blower Policy

View

Risk Management Policy

View

Related Party Transactions Policy

View

Terms of Reference of the Audit Committee

View

Uniform Code of Pharmaceuticals Marketing Practices

View

Terms & Conditions of Appointment of Independent Director

View

Environment Health and Safety Policy

View

Board Diversity Policy

View

Business Responsibility And Sustainability Policy

View

Human Right Policy

View

Code of Conduct

View

Nomination and Remuneration Policy

View

Familiarisation Programme

Details of Familiarisation Programmes during 2015-2016

View

Details of Familiarisation Programmes during 2016-2017

View

Details of Familiarisation Programmes during 2017-2018

View

Details of Familiarisation Programmes during 2018-2019

View

Details of Familiarisation programmes during 2019-2020

View

Familiarisation Programmes for Independent Directors

View

Details of Familiarisation programmes during 2020-21

View

Details of Familiarisation programmes during 2021-22

View

Details of Familiarisation programmes during 2022-23

View

Committees

CA Vijay Suresh Maniar	Chairperson
CA. Uday Kumar Gurkar	Member
Mr. Mohan A. Chandavarkar	Member
Mr. Vijay Nautamlal Bhatt	Member

Mr. Ashok A. Chandavarkar	Chairman
Mr. Ameya A. Chandavarkar	Member
Ms. Nomita R. Chandavarkar	Member

Dr. Mahesh Bijlani	Chairperson
Mr. Mohan A. Chandavarkar	Member
Mr. Ashok A. Chandavarkar	Member

Mr. Mohan A. Chandavarkar	Chairman
Mr. Ashok A. Chandavarkar	Member
Ms. Nomita R. Chandavarkar	Member
CA. Uday Kumar Gurkar	Member

CA Vijay Nautamlal Bhatt	Member
CA Uday Kumar Gurkar	Member
Dr. Mahesh Bijlani	Chairperson

Mr. Mohan A. Chandavarkar	Chairman
Mr. Ashok A. Chandavarkar	Member
Mr. Nandan M. Chandavarkar	Member

Mr. Anant Kharche	Member
Mr. Ameya Chandavarkar	Chairman
Mr. Shashank Vyapari	Member
Dr. Mahesh Bijlani	Member
CA Vijay Suresh Maniar	Member

Mr. Vijay Bhatt

Ms. Varsharani Katre

Amalgamation

NSE Observation Letter

View

BSE Observation Letter

View

Approval from RBI-Soven

View

Approval from RBI-Sudipta

View

Approval from RBI-Transgene

View

Shareholding pattern of Soven, Sudipta, Transgene, ASL & FDC as per SEBI format

View

Scheme of Amalgamation

View

Fair Exchange Report by CA

View

Audit Committee Report

View

Fairness Opinion by MB

View

Shareholding Pattern

View

Audited Financials of Soven, Sudipta, Transgene, ASL & FDC

View

Undertaking for Compliance of Clause 49

View

Complaints report

View

Notice of Court Convened Meeting

View

Notice of Postal Ballot and E-voting

View

Postal Ballot Form

View

Reporting under Clause 35A of the Listing Agreement - Details of Court Convened Meeting

View

Scrutinizer Report on Poll dated June 13,2015

View

Reporting under Clause 35A of the Listing Agreement - Details of Voting Results through Postal Ballo

View

Scrutinizer Report on E-Voting and Postal Ballot- 13 06 2015

View

Bombay High Court order

View

SEBI Approval Letter- Part B Filing- 12.10.2015

View

Amended - Memorandum and Articles of Association

View

Others

Corporate Governance

Board of Directors

CA. Uday Kumar Gurkar

Mr. Mohan A. Chandavarkar

Mr. Nandan M. Chandavarkar

Mr. Ashok A. Chandavarkar

Mr. Ameya A. Chandavarkar

Ms. Nomita R. Chandavarkar

Dr. Charuta Nityanath Mandke

Dr. Mahesh Bijlani

Mr. Vijay Suresh Maniar

Mr. Vijay Nautamlal Bhatt

Policies

Corporate Social Responsibility Policy

POLICY FOR PREVENTION, PROHIBITION AND REDRESSAL OF SEXUAL HARASSMENT AT WORKPLACE

Code of Practices & Procedures for Fair Disclosure of Unpublished Price Sensitive Information

Code Of Conduct For Prevention Of Insider Trading

Policy on Material Subsidiaries

Policy on Criteria for Determining Materiality of Events

Policy on Preservation of Documents

Policy on Dividend Distribution

Articles of Association of the Company

Whistle Blower Policy

Risk Management Policy

Related Party Transactions Policy

Terms of Reference of the Audit Committee

Uniform Code of Pharmaceuticals Marketing Practices

Terms & Conditions of Appointment of Independent Director

Environment Health and Safety Policy

Board Diversity Policy

Business Responsibility And Sustainability Policy

Human Right Policy

Code of Conduct

Nomination and Remuneration Policy

Familiarisation Programme

Details of Familiarisation Programmes during 2015-2016

Details of Familiarisation Programmes during 2016-2017

Details of Familiarisation Programmes during 2017-2018

Details of Familiarisation Programmes during 2018-2019

Details of Familiarisation programmes during 2019-2020

Familiarisation Programmes for Independent Directors

Details of Familiarisation programmes during 2020-21

Details of Familiarisation programmes during 2021-22

Details of Familiarisation programmes during 2022-23

Committees

Amalgamation

NSE Observation Letter

BSE Observation Letter

Approval from RBI-Soven

Approval from RBI-Sudipta

Approval from RBI-Transgene

Shareholding pattern of Soven, Sudipta, Transgene, ASL & FDC as per SEBI format

Scheme of Amalgamation

Fair Exchange Report by CA

Audit Committee Report

Fairness Opinion by MB

Shareholding Pattern

Audited Financials of Soven, Sudipta, Transgene, ASL & FDC

Undertaking for Compliance of Clause 49

Complaints report

Notice of Court Convened Meeting

Notice of Postal Ballot and E-voting

Postal Ballot Form

Reporting under Clause 35A of the Listing Agreement - Details of Court Convened Meeting

Scrutinizer Report on Poll dated June 13,2015

Reporting under Clause 35A of the Listing Agreement - Details of Voting Results through Postal Ballo

Scrutinizer Report on E-Voting and Postal Ballot- 13 06 2015

Bombay High Court order

SEBI Approval Letter- Part B Filing- 12.10.2015

Amended - Memorandum and Articles of Association

Others

Annual Report

Unpaid/Unclaimed Dividend

Corporate Social Responsibility

Disclosures under Regulation 46